Fundraising Fox
/Companies
Sign in

Kovina Therapeutics

Indianapolis, US · Founded 2020 · Delaware corporation · 2 known investors

Find your way into Kovina Therapeutics

Sign up to see every warm intro you have to Kovina Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Kovina Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Kovina develops first-in-class small molecule antiviral drugs to treat HPV-induced cancers and premalignant infections such as cervical and anal dysplasia. The company aims to offer non-surgical treatment options for patients living with HPV.

BiotechHealthtech

Founders & leadership

Kovina Therapeutics was founded in 2020 by Elliot Androphy.

EAElliot Androphy
Elliot AndrophyChief Scientific Officer
KSKristin Sherman
Kristin ShermanChief Executive Officer
WRWilliam Ringo
William RingoNamed on SEC filing
TWTeri Willey
Teri WilleyNon Executive Director2021–2022P2C Managing Director & Officer at Pathway to Cures
SM
Susan MahonyNamed on SEC filing

Board

FFFritz French
Fritz FrenchChairman of the Board

Investors · 2

Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M

How we know: funding news · press coverage · the VCSheet dataset · Not right? Tell us

IU Ventureslisted by IU VenturesBloomington

How we know: funding news · iuventures.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2021

▶$2MraisedJul 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William RingoDirector
  • Elliot AndrophyExecutive Officer, Director
  • Teri WilleyDirector
  • Fritz FrenchExecutive Officer, Director
  • Kristin ShermanExecutive Officer, Director
  • Susan MahonyDirector
Offering amount
$2.5M
Amount sold
$2M
Minimum investment
$50K
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Cullinan TherapeuticsCullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.
Kura OncologyKura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.

Companies working in the same space as Kovina Therapeutics.

In the news

Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer Treatment - BioSpacebiospace.com · Jun 2022

Frequently asked questions

What does Kovina Therapeutics do?
Kovina develops first-in-class small molecule antiviral drugs to treat HPV-induced cancers and premalignant infections such as cervical and anal dysplasia. The company aims to offer non-surgical treatment options for patients living with HPV.
Who founded Kovina Therapeutics?
Kovina Therapeutics was founded by Elliot Androphy in 2020.
Who are Kovina Therapeutics's investors?
Kovina Therapeutics's investors include Elevate Ventures, IU Ventures.
How much funding has Kovina Therapeutics raised?
Kovina Therapeutics has disclosed $2M raised across 1 round.
Where is Kovina Therapeutics headquartered?
Kovina Therapeutics is headquartered in Indianapolis, US.